Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
复制标题
DOI:
10.1053/spen.2002.33795
复制
发表时间:
2002-06-01
影响因子:
2.7
通讯作者:
Finkel, Richard S
中科院分区:
文献类型:
--
作者:
Bonnemann, Carsten G;Finkel, Richard S
Proteins of the sarcolemma are of crucial importance for the pathogenesis of muscular dystrophies. This update focuses on the dystrophin-associated proteins including the dystroglycan and sarcoglycan complexes, caveolin-3, dysferlin, and the extracellular matrix component collagen type VI. The molecular findings are correlated with some of the clinical phenotypes that are part of the limb-girdle muscular dystrophy spectrum, including fukutin-related proteinopathy (LGMD 21), the sarcoglycanopathies (LGMD 2C-F), caveolinopathy (LGMD 1C), dysferlinopathy (LGMD 2B), and finally Bethlem myopathy. Although recent progress has been tremendous, much remains to be learned about the pathophysiological consequences caused by a deficiency of any one of these components.